November 20th, 2026Why ST-100 is expanding from dry eye into corneal wound healingEric Schlumpf discusses why Stuart Therapeutics is taking vezocolmitide beyond dry eye disease and into corneal wound healing.Read more
November 14th, 2026How Lambert-Eaton myasthenic syndrome presents around the eyesAlfredo A. Sadun, MD, PhD, explains how LEMS mimics myasthenia gravis around the eyes and why its cancer link matters.Read more
November 13th, 2026OT Roundup: GLP-1 NAION warning, LEMS clues, Eyedaptic Eva, AFibThe FDA adds a NAION warning to GLP-1 drugs, plus LEMS clues, Eyedaptic's new Eva AI assistant and a retinal imaging link to AFib.Read more
November 8th, 2026Training refractive surgeons and expanding access to eye surgeryIsa S. K. Mohammed, MD, on training refractive surgeons and why lasers make global access harder than for cataract surgery.Read more
November 6th, 2026Empire Forum 2026: Ambati on K8 phase 2 results in geographic atrophyJayakrishna Ambati, MD, discusses phase 2 K8 results in GA, its inflammasome mechanism, and dosing designed for convenience.Read more
November 5th, 2026Global Summit for Eye Health 2026: Turning pledges into eye careHunter Cherwek, MD, of Orbis discusses summit commitments, eye care workforce training, and AI in low-resource settings.Read more
November 22nd, 2026Dry eye and Sjögren disease: Esen Akpek, MD, on screening and referralEsen Akpek, MD, discusses how a systemic Sjögren disease therapy could change dry eye screening, referral and trial end points.Read more
November 21st, 2026Q&A: GLP-1 RAs and NAION, the case for a baseline examJames Deom, OD, MPH, FAAO, FSLS, of Hazleton Eye Specialists, explains his baseline imaging approach, his nocturnal hypotension hypothesis and his same-day workup for patients on GLP-1 RAs who have sudden vision loss.Read more